TATSIS OURANIA (SVP, CRO) sold 2.0% of their position (977.00 shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $472.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/19/2026ACC: 0000875320-26-000098
Officer· SVP, CRO
Since Oct 2019
+2.52K
Net shares
Net buyer
$1.58M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
5.79K acquired · 3.27K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+5.79K
Price / share
—
Trade value
—
% of position
12.5%
2/17/2026
46.13K→51.92K
Common Stock
Direct
Shares
−2.29K
Price / share
$483.75
Trade value
$1.11M
% of position
4.4%
2/17/2026
51.92K→49.63K
Common Stock
Direct
Shares
−609.00
Price / share
$489.46
Trade value
$298.08K
% of position
1.2%
2/17/2026
49.63K→49.02K
Common Stock
Direct
Shares
−368.00
Price / share
$473.68
Trade value
$174.31K
% of position
0.8%
2/18/2026
49.02K→48.65K
Total
Net shares
+2.52K
Net value
-$1.58M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | A · Award | +5.79K | — | — | 12.5% | 46.13K | 51.92K |
| Common Stock Direct | 2/17/2026 | F · Tax Withholding | −2.29K | $483.75 | $1.11M | 4.4% | 51.92K | 49.63K |
| Common Stock Direct | 2/17/2026 | S · Sale | −609.00 | $489.46 | $298.08K | 1.2% | 49.63K | 49.02K |
| Common Stock Direct | 2/18/2026 | S · Sale | −368.00 | $473.68 | $174.31K | 0.8% | 49.02K | 48.65K |
| Total | +2.52K | -$1.58M | ||||||
Derivative Transactions0
No derivative transactions reported